Presepsin to Safely Reduce Antibiotics in Preterm Infants — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Presepsin to Safely Reduce Antibiotics in Preterm Infants — Stella

Home/Early-Onset Neonatal Sepsis/

View on ClinicalTrials.gov

Recruiting

Back to Early-Onset Neonatal Sepsis trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

Netherlands

Amsterdam UMC, Amsterdam, North Holland

Key details

Sponsor

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Enrollment target

~900 participants

Started

September 2024

Primary completion

January 2027

Last updated October 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.